Identification of necrosis-related signature for predicting prognosis and immunotherapy response in gastric cancer

Key Points

• Necrosis score predicts prognosis and immunotherapy response in gastric cancer patients, indicating its clinical utility.
• The study highlights the involvement of necrosis subtypes in the tumor microenvironment and their association with clinicopathological characteristics.
• Assessed through clinicopathological analyses, necrosis scores can guide personalized treatment approaches, enhancing therapeutic outcomes.
• Findings highlight the need for further understanding of necrosis roles in gastric cancer, suggesting future research into immunotherapeutic applications.